1. Home
  2. Labeler Index
  3. Carwin Pharmaceutical Associates, Llc
  4. 15370-104
  5. NDC Package Code: 15370-104-30 Quflora Pediatric

NDC Package 15370-104-30 Quflora Pediatric

Vitamin A Acetate,Ascorbic Acid,Cholecalciferol,.alpha.-tocopherol,Dl-,Thiamine - View Billable Units, 11-Digit Format, RxNorm

Table of Contents

    1. Package Information
    2. Frequently Asked Questions

Package Information

Find all the important details about this NDC Package code, including the 11-Digit NDC Billing number, billing units, wholesale price, RxNorm crosswalk, active ingredients, pharmacologic clasess, etc.

NDC Package Code:
15370-104-30
Package Description:
30 TABLET, CHEWABLE in 1 BOTTLE
Product Code:
15370-104
Proprietary Name:
Quflora Pediatric
Non-Proprietary Name:
Vitamin A Acetate, Ascorbic Acid, Cholecalciferol, .alpha.-tocopherol, Dl-, Thiamine Hydrochloride, Riboflavin, Niacinamide, Pyridoxine Hydrochloride, Levomefolic Acid, Folic Acid, Cyanocobalamin, Magnesium Oxide, Cupric Sulfate, And Sodium Fluoride
Substance Name:
.alpha.-tocopherol, Dl-; Ascorbic Acid; Cholecalciferol; Cupric Sulfate; Cyanocobalamin; Folic Acid; Levomefolic Acid; Magnesium Oxide; Niacinamide; Pyridoxine Hydrochloride; Riboflavin; Sodium Fluoride; Thiamine Hydrochloride; Vitamin A Acetate
Usage Information:
Quflora™ Pediatric Chewable Tablets with 0.5 mg Fluoride is a prescription dietary fluoride supplement providing twelve essential vitamins and minerals.
11-Digit NDC Billing Format:
15370010430
Billing Unit:
EA - Billing unit of "each" is used when the product is dispensed in discreet units.
NDC to RxNorm Crosswalk:
30 EA
Product Type:
Human Prescription Drug
Labeler Name:
Carwin Pharmaceutical Associates, Llc
Dosage Form:
Tablet, Chewable - A solid dosage form containing medicinal substances with or without suitable diluents that is intended to be chewed, producing a pleasant tasting residue in the oral cavity that is easily swallowed and does not leave a bitter or unpleasant after-taste.
Administration Route(s):
  • Oral - Administration to or by way of the mouth.
    • Active Ingredient(s):
  • .ALPHA.-TOCOPHEROL, DL- 15 [iU]/1
  • ASCORBIC ACID 60 mg/1
  • CHOLECALCIFEROL 400 [iU]/1
  • CUPRIC SULFATE 1 mg/1
  • CYANOCOBALAMIN 4 ug/1
  • FOLIC ACID 100 ug/1
  • LEVOMEFOLIC ACID 108 ug/1
  • MAGNESIUM OXIDE 15 mg/1
  • NIACINAMIDE 5 mg/1
  • PYRIDOXINE HYDROCHLORIDE 1.5 mg/1
  • RIBOFLAVIN 1.3 mg/1
  • SODIUM FLUORIDE .5 mg/1
  • THIAMINE HYDROCHLORIDE 1.2 mg/1
  • VITAMIN A ACETATE 1200 [iU]/1
    • Pharmacologic Class(es):
  • Analogs/Derivatives - [Chemical/Ingredient]
  • Ascorbic Acid - [CS]
  • Calculi Dissolution Agent - [EPC] (Established Pharmacologic Class)
  • Folate Analog - [EPC] (Established Pharmacologic Class)
  • Folic Acid - [CS]
  • Increased Large Intestinal Motility - [PE] (Physiologic Effect)
  • Inhibition Large Intestine Fluid/Electrolyte Absorption - [PE] (Physiologic Effect)
  • Inhibition Small Intestine Fluid/Electrolyte Absorption - [PE] (Physiologic Effect)
  • Magnesium Ion Exchange Activity - [MoA] (Mechanism of Action)
  • Osmotic Activity - [MoA] (Mechanism of Action)
  • Osmotic Laxative - [EPC] (Established Pharmacologic Class)
  • Stimulation Large Intestine Fluid/Electrolyte Secretion - [PE] (Physiologic Effect)
  • Vitamin A - [CS]
  • Vitamin A - [EPC] (Established Pharmacologic Class)
  • Vitamin B 12 - [CS]
  • Vitamin B 6 - [Chemical/Ingredient]
  • Vitamin B12 - [EPC] (Established Pharmacologic Class)
  • Vitamin B6 Analog - [EPC] (Established Pharmacologic Class)
  • Vitamin C - [EPC] (Established Pharmacologic Class)
  • Vitamin D - [CS]
  • Vitamin D - [EPC] (Established Pharmacologic Class)
    • Sample Package:
    No
    Marketing Category:
    UNAPPROVED DRUG OTHER - An unapproved drug product in a marketing category that is not reflected on a particular list.
    Start Marketing Date:
    01-06-2014
    Listing Expiration Date:
    12-31-2025
    Exclude Flag:
    N
    Code Structure:

    The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

    * Please review the disclaimer below.

    Frequently Asked Questions

    What is NDC 15370-104-30?

    The NDC Packaged Code 15370-104-30 is assigned to a package of 30 tablet, chewable in 1 bottle of Quflora Pediatric, a human prescription drug labeled by Carwin Pharmaceutical Associates, Llc. The product's dosage form is tablet, chewable and is administered via oral form.

    Is NDC 15370-104 included in the NDC Directory?

    Yes, Quflora Pediatric with product code 15370-104 is active and included in the NDC Directory. The product was first marketed by Carwin Pharmaceutical Associates, Llc on January 06, 2014 and its listing in the NDC Directory is set to expire on December 31, 2025 if the product is not updated or renewed by the manufacturer.

    What is the NDC billing unit for package 15370-104-30?

    The contents of this package are billed per "each", products billed on a per each basis are usually products dispensed in discreet units. The calculated billable units for this package is 30.

    What is the 11-digit format for NDC 15370-104-30?

    The 11-digit format is 15370010430. The 11-digit billing format might be required by the Centers for Medicare & Medicaid Services (CMS) and other payers in billing claim forms.

    This package code is originally configured in a 5-3-2 segment 10-digit format and by adding a zero within the original NDC package code we can obtain the converted 11-digit format in a 5-4-2 segment configuration. The table below shows the 11-digit code conversion:

    10-Digit Format10-Digit Original Code11-Digit Format11-Digit Code
    5-3-215370-104-305-4-215370-0104-30